Article

Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease

2022-08-05

Abstract excerpt

Elevated urine bis(monoacylglycerol)phosphate (BMP) levels have been found in gain-of-kinase function LRRK2 G2019S mutation carriers. Here, we have expanded urine BMP analysis to other Parkinson’s disease (PD) associated mutations and found them to be consistently elevated in carriers of LRRK2 G2019S and R1441G/C as well as VPS35 D620N mutations. Urine BMP levels are promising biomarkers for patient stratification...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 03f91f6b-3504-53da-bb49-684cc4a4c4ab
DOI: 10.1101/2022.08.03.22278207

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s diseaseDOI 10.1101/2022.08.03.22278207Read

Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s diseaseSemantic proximity Read

Urinary bis(monacylglycerol) phosphate (BMP) levels are higher in LRRK2 and GBA1 variant carriers but do not predict disease progression in PPMI cohortsSemantic proximity Read

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohortsSemantic proximity Read

The Impact of 90 Parkinson's Disease-Risk Single Nucleotide Polymorphisms on Urinary Bis(monoacylglycerol)phosphate Levels in the Prodromal and PD Cohorts.Semantic proximity Read

LRRK2 Kinase Activity Regulates Parkinson’s Disease-Relevant Lipids at the LysosomeSemantic proximity Read

Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and Glucocerebrosidase activitySemantic proximity Read

Biomarkers of LRRK2 and lysosomal dysfunction in Progressive Supranuclear PalsySemantic proximity Read

Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define diagnostic biosignatures for Parkinson’s DiseaseSemantic proximity Read

Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s diseaseSemantic proximity Read

The VPS35 p.A320V variant segregates with Parkinson's disease in a pesticide-exposed familySemantic proximity Read

Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease.Semantic proximity Read

Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten diseaseSemantic proximity Read